Navigation Links
ProUroCare Medical Elects Two New Directors
Date:3/5/2010

MINNEAPOLIS, March 5 /PRNewswire-FirstCall/ -- ProUroCare Medical Inc. (OTC Bulletin Board: PUMD, PUMDU and PUMDW), a provider of proprietary medical imaging products announced today the election of Michael Chambers, JD, Ph.D. and James L. Davis to its Board of Directors effective immediately.  

Michael Chambers is an experienced attorney, angel investor and entrepreneur.  Dr. Chambers currently serves as President and CEO of Swift Biotechnology, a company he recently co-founded.  Swift is pursuing development of screening technologies, developed by the Mitchell Cancer Institute, for gynecological cancers. Prior to Swift, he helped found InnoRx Pharmaceuticals in 1999, a privately held company that specialized in the development of drugs and drug delivery systems for ocular disease.  He served as President and CEO of InnoRx until negotiating its sale to SurModics in 2005.  At InnoRx he managed development of multiple pipeline technologies and licensing opportunities in the US and world-wide. He speaks fluent French and Spanish. In addition to his law degree, he was awarded a doctorate from the University of Geneva in Switzerland where he was a Swiss Confederation Fellow, and previously studied in France as a Rotary Ambassadorial Scholar. He is "Of Counsel" to the law firm of Cabaniss Johnston and frequently advises companies and academic institutions on growth, financing and licensing opportunities related to new technologies.

Mr. Davis is an active investor in ProUroCare and other entrepreneurial companies throughout the U.S.  He has considerable experience developing and implementing business and financing strategies for early stage growth companies.  He also has previous board experience and has participated in compensation reviews and policy development.  Mr. Davis is President of Davis & Associates, Inc., a company he founded more than 30 years ago that represents the leading edge lighting and controls manufacturers throughout the upper Midwest.  Mr. Davis was a founding Board Member of Arcadia Financial, LTD, which before its sale to CitiFinancial became the nation's largest independent provider of automobile financing after raising more than $315 million in debt and equity financing.  

Rick Carlson, ProUroCare's CEO, stated, "We are very pleased to have these two individuals join our Board because of their proven success in building and creating value for early stage growth companies.  They each have strong entrepreneurial and strategic planning backgrounds and previous board experience.  They will assist us in building relationships with distribution companies in the U.S. and throughout the world."

Safe Harbor Statement

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of ProUroCare's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause ProUroCare's results to differ materially from those expressed or implied by such forward-looking statements are detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q.

SOURCE ProUroCare Medical Inc.

Back to top
'/>"/>
SOURCE ProUroCare Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
2. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
3. ProUroCare Medical Inc. Announces Pricing of Equity Offering
4. ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
5. DEP Urges Medical Facilities to Take Proper Precautions With X-Ray Equipment to Avoid Health Hazards
6. FDA Provides 510k Clearance for BARRX Medicals HALO90 Ablation Catheter for the Treatment of Radiation Proctitis and Gastric Antral Vascular Ectasia (GAVE)
7. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
8. Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2010
9. Corgenix Medical Corp. Announces Launch of Products for Automated Systems
10. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
11. ATS Medical Announces Fourth Quarter and Full Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):